A Complicated Case of Transient Constrictive Pericarditis Secondary to Rivaroxaban-Associated Hemopericardium

Vardhmaan Jain; Ossama K Abou Hassan; Michael Chetrit; Agam Bansal; Mohamed M Gad; Nicholas Kassis; Allan L Klein

doi:10.1016/j.jaccas.2020.07.021

A Complicated Case of Transient Constrictive Pericarditis Secondary to Rivaroxaban-Associated Hemopericardium

JACC Case Rep. 2020 Sep 9;2(12):1947-1950. doi: 10.1016/j.jaccas.2020.07.021. eCollection 2020 Oct.

Authors

Vardhmaan Jain¹, Ossama K Abou Hassan², Michael Chetrit², Agam Bansal¹, Mohamed M Gad¹, Nicholas Kassis¹, Allan L Klein²

Affiliations

¹ Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
² Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.

Abstract

A 72-year-old man on rivaroxaban developed effusive constrictive pericarditis secondary to hemopericardium. His condition improved with anti-inflammatory therapy supporting a diagnosis of transient constrictive pericarditis. On follow-up, residual constriction developed requiring surgical pericardiectomy. Although many cases with transient constrictive pericarditis resolve with medical management, some may progress and require pericardiectomy. (Level of Difficulty: Advanced.).

Keywords: CP, constrictive pericarditis; DHE, delayed hyper-enhancement; ECP, effusive constrictive pericarditis; MRI, magnetic resonance imaging; NYHA, New York Heart Association; PWD, pulsed-wave Doppler; TCP, transient constrictive pericarditis; cardiac magnetic resonance imaging; effusive constrictive pericarditis; hemopericardium; pericarditis; recurrence; transient constrictive pericarditis.

Publication types

Case Reports